Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type 1 Env/Rev vaccine in HIV-infected recipients: Follow-up data [2]

Journal of Infectious Diseases

Volumn 181, Issue 1, 2000, Pages 406-

  MacGregor, Rob Roy ^a   Boyer, Jean D ^a   Ciccarelli, Richard B ^b   Ginsberg, Richard S ^b   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WLVP Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; LETTER; PRIORITY JOURNAL; VIRUS LOAD;

AIDS VACCINES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FOLLOW-UP STUDIES; GENE PRODUCTS, ENV; GENE PRODUCTS, REV; HIV INFECTIONS; HIV-1; HUMANS; VACCINATION; VACCINES, DNA;

EID: 0033966668     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315199     Document Type: Letter

References (0)